United States Intracranial Hemorrhage Diagnosis and Treatment Market Research Report to 2032
ID: MRFR/MED/11772-US | 100 Pages | Author: MRFR Research Team| December 2023
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
ID: MRFR/MED/11772-US | 100 Pages | Author: MRFR Research Team| December 2023
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
US Intracranial Hemorrhage Diagnosis and Treatment Market Highlighted Trends & Dynamics
The market size of the Americas reached USD 584.70 million in 2019 and is expected to grow at a rate of 5.92% by the end of the forecast period. The significant market share of 39.14% in the Americas is attributed to factors such as a high prevalence of cancer, increased spending on research, and the quick adoption of advanced treatments in the region. In the fiscal year 2020, the Department of Health and Human Services Appropriations Act, along with the 21st Century Cures Act, allocated USD 6.44 billion to the National Cancer Institute (NCI), marking a net increase of USD 297 million from the previous fiscal year. This substantial research budget is expected to lead to more grants for researchers working on innovative products and techniques for intracranial hemorrhage, with 41.3% of the NCI budget dedicated to Research Project Grants (RPGs).In addition to research grants, the region has a higher number of patients suffering from various conditions, including aneurysms. Key manufacturers are likely to introduce new products, collaborate to optimize cash flow channels, and partially outsource production processes. Furthermore, the integration of clinical data for understanding the prognosis of intracranial hemorrhage and treatment options is expected to boost research activities in the region. For example, the Radiological Society of North America (RSNA) organized the 2019 Brain CT Hemorrhage Challenge to promote a collaborative approach in constructing a machine learning dataset. The RSNA and the American Society of Neuroradiology (ASNR) worked together to curate the dataset and issued an open call for volunteers within the ASNR membership to annotate images. Within a day and a half, 140 volunteers were gathered, and 60 were selected to annotate a vast collection of 874,035 brain hemorrhage CT images in 25,312 unique exams. The increasing research spending and collaborative efforts in understanding the condition in the region are expected to contribute to the growth of the market over the forecast period.
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
